NCT01304641

Cardiovascular Events Based On Statin Initiation In The Elderly

Comparison Of Cardiovascular Event Rates In Elderly Patients With Newly Initiated Atorvastatin Or Simvastatin

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 31,603 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare rates and risk of primary cardiovascular events among elderly patients newly initiating therapy with atorvastatin or simvastatin. The specific objectives for this project are to: 1) examine the demographic and clinical characteristics of the elderly patients in whom atorvastatin or simvastatin was newly initiated; and 2) compare cardiovascular event rates in elderly patients in whom atorvastatin or simvastatin was newly initiated.

Detailed description

All subjects meeting sample definition, all inclusion criteria, and none of the exclusion criteria.

Conditions

• Cardiovascular
• Dyslipidemia

Interventions

Type	Name	Description
OTHER	Atorvastatin Initiators	Retrospective database analysis no intervention performed.
OTHER	Simvastatin Initiators	Retrospective database analysis no intervention performed.

Timeline

• Start date: 2009-11-01
• Primary completion: 2011-02-01
• Completion: 2011-02-01
• First posted: 2011-02-25
• Last updated: 2021-02-21
• Results posted: 2012-04-05